ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN
USML
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Address
- 1285 Avenue of the Americas New York NY United States of America 10019
- IPO Date
- Feb 9, 2021
- CIK
- 0001114446
- Website
- etracs.ubs.com
- Similar Companies
- Business
- ETRACS 2xLeveraged MSCI US Minimum Volatility Factor TR ETN (USML) is an exchange-traded note issued by UBS AG that provides two times (2x) leveraged exposure to the total return of the MSCI USA Minimum Volatility Factor Total Return Index. The ETN seeks to replicate twice the daily performance of the underlying index, which comprises U.S. large- and mid-cap stocks exhibiting lower volatility characteristics relative to the broader U.S. equity market; it offers investors amplified returns from low-volatility equity strategies, with principal at risk due to leverage, inverse performance potential, and daily reset compounding effects. USML features monthly coupon payments linked to the index's performance, subject to a cap and UBS's creditworthiness; it targets institutional and retail investors seeking enhanced yield and volatility-managed equity exposure in the U.S. market. The product operates within the structured products segment of the exchange-traded funds and notes industry, listed on the NYSE Arca exchange and available through major broker-dealers across the United States and select international markets. UBS AG, founded in 1862 and headquartered in Zurich, Switzerland, serves as the issuer, with operations spanning Europe, the Americas, and Asia-Pacific; no notable subsidiaries directly manage USML. In recent developments as of late 2025, UBS AG announced enhancements to its ETRACS ETN suite, including USML, through a strategic partnership with MSCI to refine index methodology for improved volatility targeting amid market turbulence; the firm completed a $500 million funding allocation for leveraged ETN expansions in Q3 2025 and launched complementary inverse volatility products in November 2025. These changes reflect UBS's shift toward dynamic risk-premia strategies, with USML experiencing a 15% assets under management increase following the updates. No reorganizations or name changes affect the product directly.